We consistently track patient outcomes in order to achieve low disease activity using JointMan, the most comprehensive rheumatology support tool available.
@ArthritisSTL@CSROAdvocacy “When the going gets tough, the tough gets going”. It’s an honor to be part of CSRO payer committee as we (CSRO) stand up for access to the right patient, with the right treatments, at the right time! Thank you CSRO for all that you do for our specialty!
@LeahHoustonMD Such a true statement! It is the complexity of our patients, interacting with our specialty medications that determine better patient outcomes! Let the rheumatologist pick the best mechanism of action drugs for our complex patients, not step therapy based on rebates and profit
@ArthritisSTL We call the insurance companies “payers” but they are just claim adjudicators, the real “payers” are employers and thankfully, they are starting to get a loud voice! They are aligned together and support local pharma, transparency, and direct contracts with providers!
@AngusWorthing@BCBST@FedEx@DollarGeneral@autozone@IntlPaperCo@TruGreen Employers want demonstrated value of evidence based therapy and employee outcomes. The right Medication for the right patients. Only physicians manage this! All stakeholders are Tired of non transparency of drug spend, the smoke and mirrors of cost savings that go as rebates.